Twist Bioscience ( (TWST) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Twist Bioscience shares are climbing as investors react to the company’s 2026 Investor Day spotlighting its AI-driven drug discovery push and the launch of its new Complex Genes program. Confidence is also being fueled by a clearer roadmap to reaching adjusted EBITDA breakeven by the fourth quarter of fiscal 2026.
On the back of these growth plans, Twist recently raised its full-year revenue guidance after a strong fiscal second quarter, adding to the bullish sentiment. Analysts have responded with a wave of price target upgrades, reinforcing the upbeat outlook for the stock.
More about Twist Bioscience
YTD Price Performance: 69.17%
Average Trading Volume: 1,237,911
Technical Sentiment Signal: Strong Buy
Current Market Cap: $3.34B
For further insights into TWST stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.